| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |